Literature DB >> 5537083

Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies.

D E Schwartz, W Vetter, G Englert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5537083

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  16 in total

1.  Proceedings: Some observations on the pharmacokinetics of trimethoprim in the horse.

Authors:  F Alexander; R A Collett
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

2.  General survey of trimethoprim combinations in the treatment of urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Efficacy of trimethoprim in murine experimental infection with a thymidine kinase-deficient mutant of Escherichia coli.

Authors:  T Tokunaga; K Oka; A Takemoto; Y Ohtsubo; N Gotoh; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 4.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

5.  Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.

Authors:  M L Grayson; C Thauvin-Eliopoulos; G M Eliopoulos; J D Yao; D V DeAngelis; L Walton; J L Woolley; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 6.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

7.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

8.  Modulation of infection by gamma interferon treatment following trauma.

Authors:  M J Hershman; H C Polk; J D Pietsch; R E Shields; S R Wellhausen; G Sonnenfeld
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

9.  Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections.

Authors:  J Aarbakke; O Opshaug; A Digranes; A Høylandskjaer; G Fluge; H Fellner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Studies on the in vitro biological N-oxidation of trimethoprim.

Authors:  P J Watkins; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.